A detailed history of Parallel Advisors, LLC transactions in Personalis, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 16,522 shares of PSNL stock, worth $86,410. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,522
Previous 16,522 -0.0%
Holding current value
$86,410
Previous $19,000 363.16%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 28, 2022

SELL
$7.56 - $14.3 $5,685 - $10,753
-752 Reduced 4.35%
16,522 $137,000
Q4 2021

Jan 20, 2022

BUY
$12.24 - $21.25 $8,935 - $15,512
730 Added 4.41%
17,274 $246,000
Q3 2021

Nov 02, 2021

BUY
$16.69 - $26.05 $367 - $573
22 Added 0.13%
16,544 $318,000
Q2 2021

Aug 06, 2021

SELL
$18.15 - $27.75 $2,196 - $3,357
-121 Reduced 0.73%
16,522 $418,000
Q1 2021

Apr 23, 2021

BUY
$20.71 - $51.02 $2,505 - $6,173
121 Added 0.73%
16,643 $410,000
Q2 2020

Jul 16, 2020

BUY
$7.65 - $14.11 $126,393 - $233,125
16,522 New
16,522 $214,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $240M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.